Waters Corporation is a publicly traded Analytical Laboratory instrument and software company headquartered in Milford, Massachusetts.
| Revenue (TTM) | $5.61B |
| Gross Profit (TTM) | $2.80B |
| EBITDA | $1.41B |
| Operating Margin | 11.40% |
| Return on Equity | 1.12% |
| Return on Assets | 2.36% |
| Revenue/Share (TTM) | $66.43 |
| Book Value | $155.63 |
| Price-to-Book | 2.91 |
| Price-to-Sales (TTM) | 8.01 |
| EV/Revenue | 8.74 |
| EV/EBITDA | 43.23 |
| Quarterly Earnings Growth (YoY) | -67.20% |
| Quarterly Revenue Growth (YoY) | 120.90% |
| Shares Outstanding | $98.19M |
| Float | $98.07M |
| % Insiders | 0.10% |
| % Institutions | 102.42% |
Volatility is currently expanding
The Madison Mid Cap Fund (Class I) returned -2.09% in the third quarter, compared to the Russell Midcap Index return of -3.00%. The top five contributors for the quarter were Gartner, Medpace Holdings, Ross Stores, Revvity, and Waters Corporation. The bottom five detractors for the quarter were MKS, Floor & Decor Holdings, Carlisle Companies, Moelis and Co., and Glacier Bancorp.
Jim Cramer just declared the companies that supply drug labs and research instruments the true heirs to the data center trade, and three stocks are already beating the NASDAQ-100 by a wide margin this year.
Waters NYSE: WAT reported third-quarter 2026 revenue of $1.767 billion and adjusted earnings per share of $4.10, as the company cited double-digit organic growth, improving performance in acquired businesses and cost actions that supported profitability.
WAT beats Q3 2026 earnings and revenue estimates, fueled by acquisitions and strong organic growth and raises its full-year revenue and earnings outlook.
Waters Corporation (WAT) Q3 2026 Earnings Call Transcript
The headline numbers for Waters (WAT) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Waters (WAT) came out with quarterly earnings of $4.1 per share, beating the Zacks Consensus Estimate of $3.99 per share. This compares to earnings of $3.4 per share a year ago.
Company to Provide Starting 2027 Growth Framework on Earnings Conference Call Third Quarter 2026 Highlights Total reported revenue of $1.767 billion exceeded guidance midpoint by $14 million, led by organic revenue growth of 9% as reported and 10% in constant currency, with acquired business revenue landing slightly ahead of guidance. GAAP EPS of $0.82; Adjusted EPS of $4.10 grew 21% and exceeded guidance.
Adds MOBILion's breakthrough SLIM high-resolution ion mobility technology, which separates molecules by size, shape and charge in milliseconds, complementing Waters' industry leading mass spectrometry platform, transforming samples to insights. Accelerates Waters' move into proteomics with research capabilities built for AI foundation and frontier models, pairing the unique speed and resolution of the Xevo™ MRT MS with data generation at the scale needed to power proteomics lab-in-the-loop research via Anthropic MCP and MHS protocol support.
WAT's Q3 results are likely to benefit from strong revenue growth prospects, rising demand and acquisition gains.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on WAT and any ticker you trade — then tracks every position and per-strategy win rate.
